RxDoctor Payments Data

Connie Wilson

Nurse Practitioner · Athol, IDNPI 1619341260

Payments from drug & device makers

$1,582in general payments, 2019–2025

Across 70 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$450
  • Exact Sciences$212
  • GSK$183
  • Insulet Corporation$179
  • Lilly USA, LLC$72
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$66
  • plus $419 from 9 others

What the payments were for

  • Food & beverage$1,582100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,582 in reported general payments places this provider in the 85th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$45,963
Medicare patients
224
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$46,502
MounjaroTirzepatide22$29,193
JardianceEmpagliflozin16$18,046
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,858
Duloxetine Hcl54$2,733
Qvar RedihalerBeclomethasone Dipropionate13$2,623
Levothyroxine Sodium197$1,716
Atorvastatin Calcium162$1,564
Gabapentin92$1,438
Omeprazole122$1,236
Rosuvastatin Calcium83$1,111
Albuterol Sulfate HfaAlbuterol Sulfate38$1,102
Potassium Chloride19$983
Celecoxib28$970
Lisinopril153$917

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$46,50249 claims
Lilly USA, LLCMounjaro$72$29,19322 claims
AbbVieSynthroid$450$79731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 570 nurse practitioner providers in Idaho.

Other nurse practitioner in Athol

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →